0001209191-21-039033.txt : 20210608
0001209191-21-039033.hdr.sgml : 20210608
20210608192015
ACCESSION NUMBER: 0001209191-21-039033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210604
FILED AS OF DATE: 20210608
DATE AS OF CHANGE: 20210608
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WEST MICHAEL D
CENTRAL INDEX KEY: 0001202529
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38519
FILM NUMBER: 211003542
MAIL ADDRESS:
STREET 1: 1010 ATLANTIC AVENUE, SUITE 102
CITY: ALAMEDA
STATE: CA
ZIP: 94501
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AgeX Therapeutics, Inc.
CENTRAL INDEX KEY: 0001708599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821436829
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 965 ATLANTIC AVENUE
STREET 2: SUITE 101
CITY: ALAMEDA
STATE: CA
ZIP: 94501
BUSINESS PHONE: 510-671-8370
MAIL ADDRESS:
STREET 1: 965 ATLANTIC AVENUE
STREET 2: SUITE 101
CITY: ALAMEDA
STATE: CA
ZIP: 94501
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-04
0
0001708599
AgeX Therapeutics, Inc.
AGE
0001202529
WEST MICHAEL D
1101 MARINA VILLAGE PARKWAY, SUITE 201
ALAMEDA
CA
94501
1
1
0
0
Chief Executive Officer
Option to Purchase Common Stock
1.45
2021-06-04
4
A
0
120000
0.00
A
2031-06-03
Common Stock
120000
120000
D
Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date.
/s/Michael D. West
2021-06-08